Long-Term Efficacy and Safety of Infliximab in the Treatment of Behçet’s Disease

By Capella María José   Foster C. Stephen  

Ocular Immunology and Inflammation, Vol. 20, Iss. 3, 2012-06 ,pp. : 198-202

Informa Healthcare

Access to resources Recommend Favorite

Infliximab Monotherapy Versus Infliximab and Colchicine Combination Therapy in Patients with Behçet’s Disease

By Takeuchi Masaki   Asukata Yuri   Kawagoe Tatsukata   Ito Norihiko   Nishide Tadayuki   Mizuki Nobuhisa  

Ocular Immunology and Inflammation, Vol. 20, Iss. 3, 2012-06 ,pp. : 193-197

Informa Healthcare

Access to resources Recommend Favorite

Clinical Experience with Adalimumab in the Treatment of Ocular Behçet Disease

By Bawazeer Ahmed   Raffa Lina H.   given-names given-names Nizamuddin  

Ocular Immunology and Inflammation, Vol. 18, Iss. 3, 2010-06 ,pp. : 226-232

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Severe Inflammatory Eye Disease in Patients of Reproductive Age and during Pregnancy

By Wakefield Denis   El-Asrar Ahmed Abu   McCluskey Peter  

Ocular Immunology and Inflammation, Vol. 20, Iss. 4, 2012-08 ,pp. : 277-287

Informa Healthcare

Access to resources Recommend Favorite

Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behçet Disease Treated with Infliximab

By Al Rashidi Sultan   Al Fawaz Abdullah   Kangave Dustan   Abu El-Asrar Ahmed M.  

Ocular Immunology and Inflammation, Vol. 21, Iss. 6, 2013-12 ,pp. : 468-474

Informa Healthcare

Access to resources Recommend Favorite